Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_assertion type Assertion NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_head.
- NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_assertion description "[In this study, we examined if treatment with sorafenib, a potent inhibitor of Raf kinase and VEGF receptor, could reverse the resistant phenotype in tumor and tumor-associated endothelial cells, thereby enhancing the therapeutic efficacy of currently used chemoradiation treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_provenance.
- NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_assertion evidence source_evidence_literature NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_provenance.
- NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_assertion SIO_000772 21551262 NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_provenance.
- NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_assertion wasDerivedFrom befree-20140225 NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_provenance.
- NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_assertion wasGeneratedBy ECO_0000203 NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_provenance.